XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar hansjang (< 20) Submitted: 2/19/2010 7:48:26 AM : Outperform Start Price: $6.82 XNPT Score: -33.20

It should be wait what FDA say for this REJECT.
And, we can do something for this company.
I am waiting for a while.
I believe what XNPT did well.

Featured Broker Partners


Advertisement